The future of the global computational biology market looks promising with opportunities in the academic & research and commercial sectors. The global computational biology market is expected to reach an estimated $12.8 billion by 2030 with a CAGR of 13.4% from 2024 to 2030. The major drivers for this market are expanding use of AI-based technology in drug discovery and growing interest in drug design and disease modeling.
Some of the key questions
answered in this exclusive report are:
Q.1. What are some of
the most promising, high-growth opportunities for the computational biology
market by service (contract and in-house), application (cellular &
biological simulation, drug discovery & disease modelling, preclinical drug
development, clinical trials, human body simulation software, and others), end
use industry (academics & research, commercial, and others), and region
(North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will
grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and
why?
Q.4. What are the key
factors affecting market dynamics? What are the key challenges and business
risks in this market?
Q.5. What are the
business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market
and the reasons behind them?
Q.7. What are some of
the changing demands of customers in the market?
Q.8. What are the new
developments in the market? Which companies are leading these developments?
Q.9. Who are the major
players in this market? What strategic initiatives are key players pursuing for
business growth?
Q.10. What are some of
the competing products in this market and how big of a threat do they pose for
loss of market share by material or product substitution?
Q.11. What M&A
activity has occurred in the last 5 years and what has its impact been on the
industry?
Market Segmentation:
In this market, cellular
& biological simulation, drug discovery & disease modelling,
preclinical drug development, clinical trial, and human body simulation
software are the major segments of computational biology market by application.
Lucintel forecasts that cellular & biological simulation is expected to witness
highest growth over the forecast period.
Within this market,
commercial is expected to witness higher growth over the forecast period due to
increasing public and private sector spending on research and development in
genetic engineering and the development of new drugs.
North America will
remain the largest region due to existence of robust healthcare infrastructure,
growing cases of chronic disease, and presence of key players in the region.
Genedata, Rhenovia
Pharma, Compugen, Chemical Computing, Certara, Nimbus Discovery, Rhenovia
Pharma & Leadscope, Simulation Plus, Entelos, and Insilico Biotechnology
are the major suppliers in the computational biology market.
About
Lucintel
Lucintel, the premier global
management consulting and market research firm, creates winning strategies for
growth. It offers market assessments, competitive analysis, opportunity
analysis, growth
consulting, M&A, and due diligence services to executives and
key decision-makers in a variety of industries.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. 972.636.5056
Related Reports
1. United States Residential Humidifier Market
2. Virtual Reality Headset Market
3. Household Appliances Market
9. LED Market
No comments:
Post a Comment